Model1 | Model2 | Model3 | Model4 | Model5 | |
---|---|---|---|---|---|
Thyroid malignant tumors | |||||
Constant β0 (SE) | 14190.437*** | 1788.894 | 1070.168 | 1725.670 | 3293.394 |
(190.756) | (8994.661) | (9658.048) | (8853.679) | (9731.808) | |
Quarterly trend before information disclosure β1 (SE) | 81.019 | 63.961 | 67.612 | 68.327 | 60.547 |
(41.936) | (41.590) | (45.064) | (41.395) | (45.874) | |
Step change when information disclosed β2 (SE) | -299.431 | -26664.581* | -25615.156* | -27630.185* | -29002.501* |
(255.339) | (10283.471) | (10368.810) | (12019.475) | (12749.264) | |
Change in trend after information disclosure β3 (SE) | 102.750* | 123.984* | 119.237* | 129.068* | 135.720* |
(43.270) | (48.531) | (48.990) | (56.223) | (59.694) | |
Season (SE) | |||||
Quarter 2 | 60.146 | - | 54.892 | - | 141.186 |
(163.675) | - | (87.740) | - | (116.260) | |
Quarter 3 | -116.192 | - | -51.382 | - | 109.029 |
(185.103) | - | (115.090) | - | (163.882) | |
Quarter 4 | -150.040 | - | -232.028 | - | -38.931 |
(254.194) | - | (178.239) | - | (202.170) | |
Specialist hospital (SE) | - | -1461.337* | -1466.718* | 7895.359 | 7896.487 |
- | (551.176) | (551.149) | (4761.454) | (4807.687) | |
Number of beds (SE) | - | -0.013 | -0.027 | 0.284 | 0.289 |
- | (0.671) | (0.683) | (0.622) | (0.637) | |
Proportion of cases with targeted diseases (SE) | - | - | - | -179.659 | -179.637 |
- | - | - | (96.934) | (97.733) | |
Colorectal malignant tumors | |||||
Constant β0 (SE) | 42121.516*** | -183075.660*** | -188307.540*** | -151438.030*** | -148564.940*** |
(1024.411) | (36358.173) | (34428.331) | (32439.770) | (29917.177) | |
Quarterly trend before information disclosure β1 (SE) | 972.0792*** | 1155.438*** | 1183.589*** | 1036.589*** | 1022.861*** |
(229.902) | (167.464) | (166.819) | (151.778) | (142.337) | |
Step change when information disclosed β2 (SE) | -2681.814 | 138755.910** | 144957.190** | 108078.170* | 106229.740* |
(1534.924) | (43086.709) | (37490.546) | (41044.968) | (37222.896) | |
Change in trend after information disclosure β3 (SE) | -528.164* | -653.446** | -682.473** | -508.969* | -499.510* |
(239.472) | (206.374) | (179.317) | (195.009) | (176.373) | |
Season (SE) | |||||
Quarter 2 | 26.152 | - | -1222.456 | - | 276.935 |
(654.642) | - | (871.206) | - | (772.597) | |
Quarter 3 | 649.018 | - | -388.033 | - | 190.861 |
(844.118) | - | (800.596) | - | (640.992) | |
Quarter 4 | 567.514 | - | -920.765 | - | -477.754 |
(1019.975) | - | (729.973) | - | (758.235) | |
Specialist hospital (SE) | - | -12038.855 | -12073.224** | 14513.611* | 14552.010* |
- | (3580.016) | (3611.290) | (5433.259) | (5475.528) | |
Number of beds (SE) | - | -6.757 | -6.834 | -3.614 | -3.628 |
- | (5.103) | (5.180) | (2.806) | (2.866) | |
Proportion of cases with targeted diseases (SE) | - | - | - | -1358.079*** | 1360.466*** |
- | - | - | (289.302) | (289.652) |